Strategies in the rational drug design.

Mavromoustakos, T; Durdagi, S; Koukoulitsa, C; Simcic, M; Papadopoulos, M G; Hodoscek, M; Grdadolnik, S Golic

Mavromoustakos, T; Durdagi, S; Koukoulitsa, C; Simcic, M; Papadopoulos, M G; Hodoscek, M; Grdadolnik, S Golic.

Affiliation

Mavromoustakos T; University of Athens, Chemistry Department 15784, Zographou Athens, Greece. tmavrom@chem.uoa.gr

Curr Med Chem ; 18(17): 2517-30, 2011.

Article in En | MEDLINE | ID: mdl-21568895

Subject(s)

Drug Design; Antineoplastic Agents; Cannabinoids/pharmacology; Fullerenes/chemistry; HIV Protease/drug effects; HIV Protease Inhibitors/chemistry; HIV Protease Inhibitors/pharmacology; Leukemia/drug therapy; Ligands; Models, Molecular; Molecular Conformation; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Peptide Synthases/antagonists & inhibitors; Pharmaceutical Preparations/chemistry; Quantitative Structure-Activity Relationship; Receptors, Cannabinoid/drug effects; Receptors, Drug/chemistry

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Drug Design Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2011 Document type: Article Affiliation country: Greece Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links